撤稿：骨肉瘤多药联合化疗方案的疗效分析及化疗反应的管理
Retracted: Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions.
作者信息
And Alternative Medicine Evidence-Based Complementary
出版信息
Evid Based Complement Alternat Med. 2023 Jul 19;2023:9835628. doi: 10.1155/2023/9835628. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/6510429.].
摘要
[本文撤回文章DOI: 10.1155/2022/6510429。]
相似文献
1
Retracted: Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions.撤稿：骨肉瘤多药联合化疗方案的疗效分析及化疗反应的管理
Evid Based Complement Alternat Med. 2023 Jul 19;2023:9835628. doi: 10.1155/2023/9835628. eCollection 2023.
2
Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions.骨肉瘤多药联合化疗方案的疗效分析及化疗反应的处理
Evid Based Complement Alternat Med. 2022 Aug 25;2022:6510429. doi: 10.1155/2022/6510429. eCollection 2022.
3
Retracted: A Cohort Study to Evaluate the Efficacy and Value of CT Perfusion Imaging in Patients with Metastatic Osteosarcoma after Chemotherapy.撤回：一项评估CT灌注成像在化疗后转移性骨肉瘤患者中的疗效和价值的队列研究。
Comput Math Methods Med. 2023 Jul 19;2023:9805234. doi: 10.1155/2023/9805234. eCollection 2023.
4
Retracted: Efficacy of Neoadjuvant Chemotherapy plus Limb-Sparing Surgery for Osteosarcoma and Its Impact on Long-Term Quality of Life.撤稿：新辅助化疗联合保肢手术治疗骨肉瘤的疗效及其对长期生活质量的影响
Evid Based Complement Alternat Med. 2023 Dec 6;2023:9850186. doi: 10.1155/2023/9850186. eCollection 2023.
5
Retracted: Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer.撤稿：阿帕替尼联合传统化疗方案治疗晚期三阴性乳腺癌患者的疗效、安全性及肿瘤标志物抑制作用
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9879023. doi: 10.1155/2023/9879023. eCollection 2023.
6
[Retracted] STK39, overexpressed in osteosarcoma, regulates osteosarcoma cell invasion and proliferation.[已撤回]STK39在骨肉瘤中过表达，调控骨肉瘤细胞的侵袭和增殖。
Oncol Lett. 2024 Jun 17;28(2):377. doi: 10.3892/ol.2024.14510. eCollection 2024 Aug.
7
Retracted: Two Different Transplant Preconditioning Regimens Combined with Irradiation and Chemotherapy in the Treatment of Childhood Leukemia: Systematic Review and Meta-Analysis.撤回：两种不同的移植预处理方案联合放疗和化疗治疗儿童白血病：系统评价和荟萃分析。
J Healthc Eng. 2023 Sep 27;2023:9862546. doi: 10.1155/2023/9862546. eCollection 2023.
8
Retracted: Correlations of Ezrin Expression with Pathological Characteristics and Prognosis of Osteosarcoma: A Meta-Analysis.撤稿：埃兹蛋白表达与骨肉瘤病理特征及预后的相关性：一项Meta分析。
ScientificWorldJournal. 2022 Oct 24;2022:9860781. doi: 10.1155/2022/9860781. eCollection 2022.
9
Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment.撤回：TP方案化疗联合立体定向放射治疗可显著优化非小细胞肺癌治疗的临床疗效。
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9806393. doi: 10.1155/2023/9806393. eCollection 2023.
10
Retracted: Guideline and Implementation of Osteosarcoma Nursing Care for Children and Adolescents.撤回：儿童和青少年骨肉瘤护理指南及实施
Appl Bionics Biomech. 2023 Aug 16;2023:9852824. doi: 10.1155/2023/9852824. eCollection 2023.
本文引用的文献
1
Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions.骨肉瘤多药联合化疗方案的疗效分析及化疗反应的处理
Evid Based Complement Alternat Med. 2022 Aug 25;2022:6510429. doi: 10.1155/2022/6510429. eCollection 2022.
Zotero 插件